Psoriasis
Latest News
Review estimates acne risk with JAK inhibitor therapy
Acne has been reported to be an adverse effect of JAK inhibitors, but not much is known about how common acne is overall.
Latest News
FDA approves bimekizumab for moderate to severe plaque psoriasis in adults
With this approval, bimekizumab becomes the only interleukin (IL)-17A and IL-17F inhibitor approved for the treatment of these patients.
Latest News
Study validates use of new psoriatic arthritis prediction tool
To develop the tool, researchers evaluated 635 patients with psoriasis from a prospective longitudinal cohort study evaluating risk factors for...
News
Psoriasis, psoriatic arthritis insurance coverage remains restrictive
A database review showed restrictive coverage of specialty medications for psoriatic disease beyond the label indications.
News
Should patients with PsA or ankylosing spondylitis with axial disease be ‘lumped’ or ‘split’?
Patients with isolated axial psoriatic arthritis (PsA) were older at diagnosis, more likely to have psoriatic nail lesions, and less likely to...
News
Autoimmune disease patients’ waxing, waning response to COVID vaccination studied in-depth
Patients with immune-mediated inflammatory diseases have weaker vaccine-induced immunity to COVID but are able to build a humoral immune response...
News
Drug survival study looks at what lasts longest in RA, axSpA, PsA, and psoriasis
Survival rates were highest for rituximab in rheumatoid arthritis and golimumab in axial spondyloarthritis in a study of two Danish registries.
News
Proactive infliximab monitoring found best for sustaining control of inflammatory diseases
Proactive therapeutic drug monitoring with maintenance infliximab proved more effective in sustaining disease control than did standard care in...
News
Better COVID-19 outcomes confirmed in TNF inhibitor users
A study of three international registries confirms that patients with immune-mediated inflammatory diseases who are taking a TNF inhibitor should...
News
Study of biologics’ impact on psoriasis-to-PsA transition contradicts previous findings
Differing patient selection criteria and other biases may be why results from a large EHR administrative database study contradict those from...